DeutschNewstral
Article
Haaretz on 2019-02-06 02:31
Business in Brief: Teva Clears Way to Sell Medical-device Unit
Related news
- Business in Brief: Teva in Talks to Sell Medical Equipment Manufacturer at $80 MillionHaaretz
- Business in Brief: Teva Threatened With Strike at Main Plant for Making Top-selling Copaxone DrugHaaretz
- Business in Brief: Teva Reaches $135m Settlement With Illinois Over Wholesale Drug PricesHaaretz
- Business in Brief: Teva Pushes Back Completion of Allergan Deal to JuneHaaretz
- FTeva closes in on Allergan’s generics unitft.com
- FAllergan sells generic drugs unit to Tevaft.com
- Business in Brief: Teva Patent Dispute With Swiss Firm Reaches U.S. Supreme CourtHaaretz
- Business in Brief: India’s Dr. Reddy’s to Buy Eight Generic Drugs From Teva and AllerganHaaretz
- Business in Brief / Teva said to be eyeing Mexican drug makerHaaretz
Teva in $35M deal with implantable drug-delivery device makerbizjournals.com- Business in Brief: SodaStream Advertises Carbonated-bathwater Device in April Fool's PrankHaaretz
- Teva drops bid for Mylan, buys Allergan's generic drug unitbizjournals.com
Teva nears deal for Allergan’s generic drugs unitThe Globe and Mail- Teva to sell Wayne company's pain drug in Israelbizjournals.com
- Business in Brief: Teva Faces U.S. Setback on Migraine DrugHaaretz
- Business in Brief / Teva secures $33.75b loan for Allergan dealHaaretz
- Business in Brief: Teva Pharm to Move Headquarters to Tel AvivHaaretz
- Business in Brief: Teva Leads Sharp Rise in Tel Aviv SharesHaaretz
Teva in Talks to Buy Allergan Unit in $45 Billion Dealwsj.com
Allergan to sell a quarter of its Teva stake in first quarter of 2018Reuters